Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pralatrexate and Gemcitabine in Relapsed/Refractory Lymphoproliferative Malignancies
NCT00481871Phase 2Completed
- Sponsor
- Acrotech Biopharma Inc
- Start
- May 2007
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pralatrexate in Hodgkin lymphoma (HL), peripheral T-cell lymphoma (PTCL), B cell lymphoma, Waldenstrom macroglobulinemia (WM), sponsored by Acrotech Biopharma Inc. Started May 2007; status: completed.
02
Drugs
pralatrexate
03
Conditions
Hodgkin lymphoma (HL)peripheral T-cell lymphoma (PTCL)B cell lymphomaWaldenstrom macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT00481871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481871.